EpiVario looks to biotech for PTSD treatment - Labiotech.eu

8/22/2022 12:00:00 AM2 years 8 months ago
by Jim Cornall
by Jim Cornall
U.S. biotech company EpiVario has highlighted research findings that could lead to a treatment approach for post-traumatic stress disorder.
Emerging U.S. biotech company EpiVario, Inc. has highlighted preclinical research findings that could lead to a treatment approach for post-traumatic stress disorder (PTSD). Published in Proceeding… [+4983 chars]
full article...